Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality.

Junji Kurashige, Genta Sawada, Yusuke Takahashi, Hidetoshi Eguchi, Tomoya Sudo, Toru Ikegami, Tomoharu Yoshizumi, Yuji Soejima, Tetsuo Ikeda, Hirofumi Kawanaka, Hideaki Uchiyama, Yo Ichi Yamashita, Masaru Morita, Eiji Oki, Hiroshi Saeki, Keishi Sugimachi, Masayuki Watanabe, Masaki Mori, Hideo Baba, Koshi Mimori

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Myelin and lymphocyte-associated protein gene (MAL), which is located on the long arm of chromosome 2, assigned to the region cen-q13 in humans, has been reported as tumor suppressor in several cancers. The aim of this study was to clarify the clinical significance of MAL gene in gastric cancer. The expression levels of MAL mRNA was examined using 50 resected gastric cancer specimens used by laser microdissected to determine the clinicopathological significance. MAL expression was then examined by real-time quantitative PCR assay, and we analyzed the correlation between MAL expression and clinicopathological factors. In clinicopathologic analysis, the low MAL expression group showed significantly higher incidence of lymph node metastasis than the high expression group (79% and 46%, respectively, p < 0.05). Furthermore, the low MAL expression group had a significantly poorer prognosis than the high expression group (p < 0.05). The MAL gene repression related with lymph node metastasis and poor prognosis in gastric cancer, suggesting that the MAL may be a new candidate node metastasis-suppressor gene for gastric cancer.

Original languageEnglish
Pages (from-to)344-349
Number of pages6
JournalUnknown Journal
Volume104
Issue number10
Publication statusPublished - Oct 2013

Fingerprint

Stomach Neoplasms
gene expression
cancer
Neoplasm Metastasis
Gene Expression
mortality
Mortality
Myelin and Lymphocyte-Associated Proteolipid Proteins
gene
Lymph Nodes
Genes
Chromosomes, Human, Pair 2
Tumor Suppressor Genes
Real-Time Polymerase Chain Reaction
Neoplasms
Lasers
tumor
chromosome
Messenger RNA
laser

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kurashige, J., Sawada, G., Takahashi, Y., Eguchi, H., Sudo, T., Ikegami, T., ... Mimori, K. (2013). Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality. Unknown Journal, 104(10), 344-349.

Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality. / Kurashige, Junji; Sawada, Genta; Takahashi, Yusuke; Eguchi, Hidetoshi; Sudo, Tomoya; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Ikeda, Tetsuo; Kawanaka, Hirofumi; Uchiyama, Hideaki; Yamashita, Yo Ichi; Morita, Masaru; Oki, Eiji; Saeki, Hiroshi; Sugimachi, Keishi; Watanabe, Masayuki; Mori, Masaki; Baba, Hideo; Mimori, Koshi.

In: Unknown Journal, Vol. 104, No. 10, 10.2013, p. 344-349.

Research output: Contribution to journalArticle

Kurashige, J, Sawada, G, Takahashi, Y, Eguchi, H, Sudo, T, Ikegami, T, Yoshizumi, T, Soejima, Y, Ikeda, T, Kawanaka, H, Uchiyama, H, Yamashita, YI, Morita, M, Oki, E, Saeki, H, Sugimachi, K, Watanabe, M, Mori, M, Baba, H & Mimori, K 2013, 'Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality.', Unknown Journal, vol. 104, no. 10, pp. 344-349.
Kurashige J, Sawada G, Takahashi Y, Eguchi H, Sudo T, Ikegami T et al. Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality. Unknown Journal. 2013 Oct;104(10):344-349.
Kurashige, Junji ; Sawada, Genta ; Takahashi, Yusuke ; Eguchi, Hidetoshi ; Sudo, Tomoya ; Ikegami, Toru ; Yoshizumi, Tomoharu ; Soejima, Yuji ; Ikeda, Tetsuo ; Kawanaka, Hirofumi ; Uchiyama, Hideaki ; Yamashita, Yo Ichi ; Morita, Masaru ; Oki, Eiji ; Saeki, Hiroshi ; Sugimachi, Keishi ; Watanabe, Masayuki ; Mori, Masaki ; Baba, Hideo ; Mimori, Koshi. / Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality. In: Unknown Journal. 2013 ; Vol. 104, No. 10. pp. 344-349.
@article{164b9dce74404b3cb79e26dc781f30b6,
title = "Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality.",
abstract = "The Myelin and lymphocyte-associated protein gene (MAL), which is located on the long arm of chromosome 2, assigned to the region cen-q13 in humans, has been reported as tumor suppressor in several cancers. The aim of this study was to clarify the clinical significance of MAL gene in gastric cancer. The expression levels of MAL mRNA was examined using 50 resected gastric cancer specimens used by laser microdissected to determine the clinicopathological significance. MAL expression was then examined by real-time quantitative PCR assay, and we analyzed the correlation between MAL expression and clinicopathological factors. In clinicopathologic analysis, the low MAL expression group showed significantly higher incidence of lymph node metastasis than the high expression group (79{\%} and 46{\%}, respectively, p < 0.05). Furthermore, the low MAL expression group had a significantly poorer prognosis than the high expression group (p < 0.05). The MAL gene repression related with lymph node metastasis and poor prognosis in gastric cancer, suggesting that the MAL may be a new candidate node metastasis-suppressor gene for gastric cancer.",
author = "Junji Kurashige and Genta Sawada and Yusuke Takahashi and Hidetoshi Eguchi and Tomoya Sudo and Toru Ikegami and Tomoharu Yoshizumi and Yuji Soejima and Tetsuo Ikeda and Hirofumi Kawanaka and Hideaki Uchiyama and Yamashita, {Yo Ichi} and Masaru Morita and Eiji Oki and Hiroshi Saeki and Keishi Sugimachi and Masayuki Watanabe and Masaki Mori and Hideo Baba and Koshi Mimori",
year = "2013",
month = "10",
language = "English",
volume = "104",
pages = "344--349",
journal = "Quaternary International",
issn = "1040-6182",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality.

AU - Kurashige, Junji

AU - Sawada, Genta

AU - Takahashi, Yusuke

AU - Eguchi, Hidetoshi

AU - Sudo, Tomoya

AU - Ikegami, Toru

AU - Yoshizumi, Tomoharu

AU - Soejima, Yuji

AU - Ikeda, Tetsuo

AU - Kawanaka, Hirofumi

AU - Uchiyama, Hideaki

AU - Yamashita, Yo Ichi

AU - Morita, Masaru

AU - Oki, Eiji

AU - Saeki, Hiroshi

AU - Sugimachi, Keishi

AU - Watanabe, Masayuki

AU - Mori, Masaki

AU - Baba, Hideo

AU - Mimori, Koshi

PY - 2013/10

Y1 - 2013/10

N2 - The Myelin and lymphocyte-associated protein gene (MAL), which is located on the long arm of chromosome 2, assigned to the region cen-q13 in humans, has been reported as tumor suppressor in several cancers. The aim of this study was to clarify the clinical significance of MAL gene in gastric cancer. The expression levels of MAL mRNA was examined using 50 resected gastric cancer specimens used by laser microdissected to determine the clinicopathological significance. MAL expression was then examined by real-time quantitative PCR assay, and we analyzed the correlation between MAL expression and clinicopathological factors. In clinicopathologic analysis, the low MAL expression group showed significantly higher incidence of lymph node metastasis than the high expression group (79% and 46%, respectively, p < 0.05). Furthermore, the low MAL expression group had a significantly poorer prognosis than the high expression group (p < 0.05). The MAL gene repression related with lymph node metastasis and poor prognosis in gastric cancer, suggesting that the MAL may be a new candidate node metastasis-suppressor gene for gastric cancer.

AB - The Myelin and lymphocyte-associated protein gene (MAL), which is located on the long arm of chromosome 2, assigned to the region cen-q13 in humans, has been reported as tumor suppressor in several cancers. The aim of this study was to clarify the clinical significance of MAL gene in gastric cancer. The expression levels of MAL mRNA was examined using 50 resected gastric cancer specimens used by laser microdissected to determine the clinicopathological significance. MAL expression was then examined by real-time quantitative PCR assay, and we analyzed the correlation between MAL expression and clinicopathological factors. In clinicopathologic analysis, the low MAL expression group showed significantly higher incidence of lymph node metastasis than the high expression group (79% and 46%, respectively, p < 0.05). Furthermore, the low MAL expression group had a significantly poorer prognosis than the high expression group (p < 0.05). The MAL gene repression related with lymph node metastasis and poor prognosis in gastric cancer, suggesting that the MAL may be a new candidate node metastasis-suppressor gene for gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=84897570945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897570945&partnerID=8YFLogxK

M3 - Article

C2 - 24511665

AN - SCOPUS:84897570945

VL - 104

SP - 344

EP - 349

JO - Quaternary International

JF - Quaternary International

SN - 1040-6182

IS - 10

ER -